1.
Santamato A, Ranieri M, Panza F, Frisardi V, Micello MF, Filoni S, et al. Effectiveness of Switching Therapy from Complexing Protein-containing Botulinum Toxin Type A to a Formulation with Low Immunogenicity in Spasticity after Stroke: A case report. JRM [Internet]. 2012 Jun. 7 [cited 2024 Nov. 22];44(9):795-7. Available from: https://medicaljournalssweden.se/jrm/article/view/16098